PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Amity Institute of Virology and Immunology, Amity University, Noida, India. Electronic address: hprakash@amity.edu.\', \'Amity Institute of Virology and Immunology, Amity University, Noida, India.\', \'Hopp Children\'s Cancer Center, Heidelberg, Germany.\', \'Department of Zoology, Central University of Punjab, Bathinda, India.\', \'Institute of Nutritional Science, Department of Nutritional Toxicology, University of Potsdam Nuthetal, Germany.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S1098-8823(20)30097-610.1016/j.prostaglandins.2020.106504
?:hasPublicationType
?:journal
  • Prostaglandins & other lipid mediators
is ?:pmid of
?:pmid
?:pmid
  • 33147503
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Host sphingolipids: Perspective immune adjuvant for controlling SARS-CoV-2 infection for managing COVID-19 disease.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33147503>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33147503>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all